Cargando…
FAM46C-mediated tumor heterogeneity predicts extramedullary metastasis and poorer survival in multiple myeloma
Cancers originate from a single cell according to Nowell’s theory of clonal evolution. The enrichment of the most aggressive clones has been developed and the heterogeneity arises for genomic instability and environmental selection. Multiple myeloma (MM) is a multiple relapse plasma cell cancer gene...
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10449297/ https://www.ncbi.nlm.nih.gov/pubmed/37155154 http://dx.doi.org/10.18632/aging.204697 |
_version_ | 1785094928148201472 |
---|---|
author | Zhang, Weilong Wu, Chaoling Geng, Shuang Wang, Jing Yan, Changjian Zhang, Xiannian Zhang, Jia-jia Wu, Fan Pang, Yuhong Zhong, Yuping Wang, Jianbin Fu, Wei Huang, Xin Wang, Wenming Lyu, Xiaoqing Huang, Yanyi Jing, Hongmei |
author_facet | Zhang, Weilong Wu, Chaoling Geng, Shuang Wang, Jing Yan, Changjian Zhang, Xiannian Zhang, Jia-jia Wu, Fan Pang, Yuhong Zhong, Yuping Wang, Jianbin Fu, Wei Huang, Xin Wang, Wenming Lyu, Xiaoqing Huang, Yanyi Jing, Hongmei |
author_sort | Zhang, Weilong |
collection | PubMed |
description | Cancers originate from a single cell according to Nowell’s theory of clonal evolution. The enrichment of the most aggressive clones has been developed and the heterogeneity arises for genomic instability and environmental selection. Multiple myeloma (MM) is a multiple relapse plasma cell cancer generated from bone marrow. Although there were accumulating researches in multiple myeloma pathogenesis, the heterogeneity remains poorly understood. The participants enrolled in this study were 4 EMP+ (EMP, Extramedullary plasmacytoma) and 2 EMP- primarily untreated MM patients. Single cell RNA sequencing and analysis were conducted for the single cell suspension, which was sorted by flow cytometry from peripheral blood mononuclear cells or bone marrow cells. In our research, the results of single cell RNA sequencing show that FAM46C determines MM tumor heterogeneity predicting extramedullary metastasis by influencing RNA stability. Further, we integrated and analyzed 2280 multiple myeloma samples from 7 independent datasets, which uncover that FAM46C mediated tumor heterogeneity predicts poorer survival in multiple myeloma. |
format | Online Article Text |
id | pubmed-10449297 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Impact Journals |
record_format | MEDLINE/PubMed |
spelling | pubmed-104492972023-08-25 FAM46C-mediated tumor heterogeneity predicts extramedullary metastasis and poorer survival in multiple myeloma Zhang, Weilong Wu, Chaoling Geng, Shuang Wang, Jing Yan, Changjian Zhang, Xiannian Zhang, Jia-jia Wu, Fan Pang, Yuhong Zhong, Yuping Wang, Jianbin Fu, Wei Huang, Xin Wang, Wenming Lyu, Xiaoqing Huang, Yanyi Jing, Hongmei Aging (Albany NY) Research Paper Cancers originate from a single cell according to Nowell’s theory of clonal evolution. The enrichment of the most aggressive clones has been developed and the heterogeneity arises for genomic instability and environmental selection. Multiple myeloma (MM) is a multiple relapse plasma cell cancer generated from bone marrow. Although there were accumulating researches in multiple myeloma pathogenesis, the heterogeneity remains poorly understood. The participants enrolled in this study were 4 EMP+ (EMP, Extramedullary plasmacytoma) and 2 EMP- primarily untreated MM patients. Single cell RNA sequencing and analysis were conducted for the single cell suspension, which was sorted by flow cytometry from peripheral blood mononuclear cells or bone marrow cells. In our research, the results of single cell RNA sequencing show that FAM46C determines MM tumor heterogeneity predicting extramedullary metastasis by influencing RNA stability. Further, we integrated and analyzed 2280 multiple myeloma samples from 7 independent datasets, which uncover that FAM46C mediated tumor heterogeneity predicts poorer survival in multiple myeloma. Impact Journals 2023-05-06 /pmc/articles/PMC10449297/ /pubmed/37155154 http://dx.doi.org/10.18632/aging.204697 Text en Copyright: © 2023 Zhang et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/3.0/) (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Paper Zhang, Weilong Wu, Chaoling Geng, Shuang Wang, Jing Yan, Changjian Zhang, Xiannian Zhang, Jia-jia Wu, Fan Pang, Yuhong Zhong, Yuping Wang, Jianbin Fu, Wei Huang, Xin Wang, Wenming Lyu, Xiaoqing Huang, Yanyi Jing, Hongmei FAM46C-mediated tumor heterogeneity predicts extramedullary metastasis and poorer survival in multiple myeloma |
title | FAM46C-mediated tumor heterogeneity predicts extramedullary metastasis and poorer survival in multiple myeloma |
title_full | FAM46C-mediated tumor heterogeneity predicts extramedullary metastasis and poorer survival in multiple myeloma |
title_fullStr | FAM46C-mediated tumor heterogeneity predicts extramedullary metastasis and poorer survival in multiple myeloma |
title_full_unstemmed | FAM46C-mediated tumor heterogeneity predicts extramedullary metastasis and poorer survival in multiple myeloma |
title_short | FAM46C-mediated tumor heterogeneity predicts extramedullary metastasis and poorer survival in multiple myeloma |
title_sort | fam46c-mediated tumor heterogeneity predicts extramedullary metastasis and poorer survival in multiple myeloma |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10449297/ https://www.ncbi.nlm.nih.gov/pubmed/37155154 http://dx.doi.org/10.18632/aging.204697 |
work_keys_str_mv | AT zhangweilong fam46cmediatedtumorheterogeneitypredictsextramedullarymetastasisandpoorersurvivalinmultiplemyeloma AT wuchaoling fam46cmediatedtumorheterogeneitypredictsextramedullarymetastasisandpoorersurvivalinmultiplemyeloma AT gengshuang fam46cmediatedtumorheterogeneitypredictsextramedullarymetastasisandpoorersurvivalinmultiplemyeloma AT wangjing fam46cmediatedtumorheterogeneitypredictsextramedullarymetastasisandpoorersurvivalinmultiplemyeloma AT yanchangjian fam46cmediatedtumorheterogeneitypredictsextramedullarymetastasisandpoorersurvivalinmultiplemyeloma AT zhangxiannian fam46cmediatedtumorheterogeneitypredictsextramedullarymetastasisandpoorersurvivalinmultiplemyeloma AT zhangjiajia fam46cmediatedtumorheterogeneitypredictsextramedullarymetastasisandpoorersurvivalinmultiplemyeloma AT wufan fam46cmediatedtumorheterogeneitypredictsextramedullarymetastasisandpoorersurvivalinmultiplemyeloma AT pangyuhong fam46cmediatedtumorheterogeneitypredictsextramedullarymetastasisandpoorersurvivalinmultiplemyeloma AT zhongyuping fam46cmediatedtumorheterogeneitypredictsextramedullarymetastasisandpoorersurvivalinmultiplemyeloma AT wangjianbin fam46cmediatedtumorheterogeneitypredictsextramedullarymetastasisandpoorersurvivalinmultiplemyeloma AT fuwei fam46cmediatedtumorheterogeneitypredictsextramedullarymetastasisandpoorersurvivalinmultiplemyeloma AT huangxin fam46cmediatedtumorheterogeneitypredictsextramedullarymetastasisandpoorersurvivalinmultiplemyeloma AT wangwenming fam46cmediatedtumorheterogeneitypredictsextramedullarymetastasisandpoorersurvivalinmultiplemyeloma AT lyuxiaoqing fam46cmediatedtumorheterogeneitypredictsextramedullarymetastasisandpoorersurvivalinmultiplemyeloma AT huangyanyi fam46cmediatedtumorheterogeneitypredictsextramedullarymetastasisandpoorersurvivalinmultiplemyeloma AT jinghongmei fam46cmediatedtumorheterogeneitypredictsextramedullarymetastasisandpoorersurvivalinmultiplemyeloma |